Overview

Antidepressant Maintenance in Traumatic Brain Injury

Status:
Unknown status
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to explore to what extent continuing the antidepressant medication citalopram (Celexa), after depression has responded to treatment, helps prevent the return of depressive symptoms in patients with recent traumatic brain injury (TBI).
Phase:
Phase 4
Details
Lead Sponsor:
Ontario Neurotrauma Foundation
Treatments:
Antidepressive Agents
Citalopram
Dexetimide